"Diabetic Retinopathy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.
| Descriptor ID |
D003930
|
| MeSH Number(s) |
C11.768.257 C14.907.320.382 C19.246.099.500.382
|
| Concept/Terms |
Diabetic Retinopathy- Diabetic Retinopathy
- Diabetic Retinopathies
- Retinopathies, Diabetic
- Retinopathy, Diabetic
|
Below are MeSH descriptors whose meaning is more general than "Diabetic Retinopathy".
Below are MeSH descriptors whose meaning is more specific than "Diabetic Retinopathy".
This graph shows the total number of publications written about "Diabetic Retinopathy" by people in this website by year, and whether "Diabetic Retinopathy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 0 | 1 | 1 |
| 2002 | 1 | 0 | 1 |
| 2003 | 2 | 1 | 3 |
| 2005 | 0 | 1 | 1 |
| 2006 | 1 | 0 | 1 |
| 2007 | 1 | 2 | 3 |
| 2011 | 1 | 0 | 1 |
| 2012 | 2 | 0 | 2 |
| 2013 | 4 | 0 | 4 |
| 2014 | 1 | 1 | 2 |
| 2015 | 3 | 0 | 3 |
| 2016 | 5 | 1 | 6 |
| 2017 | 6 | 0 | 6 |
| 2018 | 4 | 0 | 4 |
| 2019 | 1 | 0 | 1 |
| 2021 | 2 | 0 | 2 |
| 2022 | 4 | 0 | 4 |
| 2023 | 4 | 0 | 4 |
| 2024 | 3 | 1 | 4 |
| 2025 | 3 | 1 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Diabetic Retinopathy" by people in Profiles.
-
Lang TZ, Xu BY, Li Z, Iyengar S, Kesselman C, Ambite JL, Bolo K, Do J, Wong B, Daskivich LP. Acute Angle Closure Incidence in a Large Countywide Safety Net Teleretinal Screening Program. JAMA Ophthalmol. 2025 Nov 01; 143(11):883-890.
-
Callan A, Heckman J, Tah G, Lopez S, Valdez L, Tsin A. VEGF in Diabetic Retinopathy and Age-Related Macular Degeneration. Int J Mol Sci. 2025 May 22; 26(11).
-
Ko MY, Talebi R, Yu F, Tseng VL, Coleman AL, Hosseini H. Socioeconomic Disparities in Intravitreal Injection Use and Anti-VEGF Agent Selection: Aflibercept/Ranibizumab Versus Bevacizumab. Clin Ther. 2025 Aug; 47(8):559-565.
-
Rorex C, Cardona SM, Church KA, Rodriguez D, Vanegas D, Saldivar RA, El-Sheikh A, Wang Y, Gyoneva S, Cotleur AC, Cardona AE. CX3CR1-Fractalkine Dysregulation Affects Retinal GFAP Expression, Inflammatory Gene Induction, and LPS Response in a Mouse Model of Hypoxic Retinopathy. Int J Mol Sci. 2025 Jan 28; 26(3).
-
Rorex C, Cardona SM, Church KA, Rodriguez D, Vanegas D, Saldivar R, Faz B, Cardona AE. Astrogliosis in the GFAP-CreERT2:Rosa26iDTR Mouse Model Does Not Exacerbate Retinal Microglia Activation or M?ller Cell Gliosis under Hypoxic Conditions. Biomolecules. 2024 May 10; 14(5).
-
Callan A, Jha S, Valdez L, Baldado L, Tsin A. TGF-? Signaling Pathways in the Development of Diabetic Retinopathy. Int J Mol Sci. 2024 Mar 06; 25(5).
-
Rodriguez D, Church KA, Smith CT, Vanegas D, Cardona SM, Muzzio IA, Nash KR, Cardona AE. Therapeutic Delivery of Soluble Fractalkine Ameliorates Vascular Dysfunction in the Diabetic Retina. Int J Mol Sci. 2024 Jan 31; 25(3).
-
Callan A, Jha S, Valdez L, Tsin A. Cellular and Molecular Mechanisms of Neuronal Degeneration in Early-Stage Diabetic Retinopathy. Curr Vasc Pharmacol. 2024; 22(5):301-315.
-
Au A, Bajar BT, Wong BM, Daskivich LP, Hosseini H, Prasad PS. Systemic and ocular outcomes in patients with young-onset type 2 diabetes. J Diabetes Complications. 2024 02; 38(2):108670.
-
Gandhi M, Daskivich LP, Ogunyemi OI. DRRisk: A Web-based tool to Assess the Risk of Diabetic Retinopathy through Machine Learning on Electronic Health Records. AMIA Annu Symp Proc. 2022; 2022:452-460.